CVS Health Corporation (CVS)
NYSE: CVS · Real-Time Price · USD
98.32
-0.84 (-0.85%)
At close: Jun 18, 2026, 4:00 PM EDT
98.40
+0.08 (0.08%)
After-hours: Jun 18, 2026, 7:56 PM EDT
CVS Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5,880 | 1,728 | 4,586 | 8,368 | 4,327 | 7,989 |
Depreciation & Amortization | 2,262 | 4,606 | 4,597 | 4,366 | 4,224 | 4,486 |
Stock-Based Compensation | 401 | 535 | 540 | 588 | 447 | 484 |
Other Adjustments | 451 | 5,244 | -725 | 89 | 361 | 1,449 |
Change in Receivables | 2,834 | -3,498 | -1,301 | -6,260 | -2,971 | -2,703 |
Changes in Inventories | 1,191 | -1,267 | -102 | 1,233 | -1,435 | 735 |
Changes in Accounts Payable | -1,759 | 3,855 | 2,335 | 3,618 | 4,260 | 2,898 |
Changes in Other Operating Activities | -3,285 | -564 | -823 | 1,424 | 6,964 | 2,927 |
Operating Cash Flow | 10,332 | 10,639 | 9,107 | 13,426 | 16,177 | 18,265 |
Operating Cash Flow Growth | 17.95% | 16.82% | -32.17% | -17.01% | -11.43% | 15.13% |
Capital Expenditures | -2,938 | -2,832 | -2,781 | -3,031 | -2,727 | -2,520 |
Purchases of Investments | -15,646 | -15,012 | -15,191 | -9,043 | -7,746 | -9,963 |
Proceeds from Sale of Investments | 13,008 | 12,383 | 10,353 | 7,729 | 6,729 | 7,246 |
Payments for Business Acquisitions | -421 | -436 | -95 | -16,612 | -139 | -146 |
Proceeds from Business Divestments | - | - | - | - | -1,249 | - |
Other Investing Activities | 14 | 26 | 101 | 68 | 85 | 122 |
Investing Cash Flow | -5,983 | -5,871 | -7,613 | -20,889 | -5,047 | -5,261 |
Short-Term Debt Issued | -1,260 | -2,119 | 1,919 | 5,200 | - | - |
Short-Term Debt Repaid | - | - | - | -5,000 | - | - |
Net Short-Term Debt Issued (Repaid) | -1,260 | -2,119 | 1,919 | 200 | - | - |
Long-Term Debt Issued | 3,969 | 3,969 | 7,913 | 10,898 | - | 987 |
Long-Term Debt Repaid | -4,404 | -3,629 | -4,773 | -3,166 | -4,211 | -10,254 |
Net Long-Term Debt Issued (Repaid) | -435 | 340 | 3,140 | 7,732 | -4,211 | -9,267 |
Issuance of Common Stock | 353 | 394 | 361 | 277 | 551 | 549 |
Repurchase of Common Stock | -156 | -158 | -3,208 | -2,193 | -3,870 | -168 |
Net Common Stock Issued (Repurchased) | 197 | 236 | -2,847 | -1,916 | -3,319 | 381 |
Common Dividends Paid | -3,404 | -3,397 | -3,373 | -3,132 | -2,907 | -2,625 |
Other Financing Activities | -24 | - | 26 | -201 | -79 | 155 |
Financing Cash Flow | -4,926 | -4,940 | -1,135 | 2,683 | -10,516 | -11,356 |
Net Cash Flow | -577 | -172 | 359 | -4,780 | 614 | 1,648 |
Free Cash Flow | 7,394 | 7,807 | 6,326 | 10,395 | 13,450 | 15,745 |
Free Cash Flow Growth | -5.29% | 23.41% | -39.14% | -22.71% | -14.58% | 17.26% |
FCF Margin | 1.81% | 1.94% | 1.70% | 2.91% | 4.17% | 5.39% |
Free Cash Flow Per Share | 5.80 | 6.14 | 5.01 | 8.06 | 10.17 | 11.85 |
Levered Free Cash Flow | -3,292 | 3,787 | 12,899 | 23,886 | 11,386 | 7,260 |
Unlevered Free Cash Flow | 480.92 | 7,568 | 9,578 | 17,903 | 17,183 | 18,617 |